Amarantus Bioscience Holdings Stock Net Income
As of the 6th of February, Amarantus Bioscience shows the risk adjusted performance of (0.08), and Mean Deviation of 1.99. Amarantus Bioscience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Amarantus Bioscience risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if Amarantus Bioscience is priced correctly, providing market reflects its regular price of 0.0 per share.
Amarantus Bioscience's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amarantus Bioscience's valuation are provided below:Amarantus Bioscience Holdings does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Amarantus |
Amarantus Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amarantus Bioscience's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amarantus Bioscience.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Amarantus Bioscience on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Amarantus Bioscience Holdings or generate 0.0% return on investment in Amarantus Bioscience over 90 days. Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeut... More
Amarantus Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amarantus Bioscience's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amarantus Bioscience Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 66.67 |
Amarantus Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amarantus Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amarantus Bioscience's standard deviation. In reality, there are many statistical measures that can use Amarantus Bioscience historical prices to predict the future Amarantus Bioscience's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | 1.43 |
Amarantus Bioscience February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 1.44 | |||
| Mean Deviation | 1.99 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 8.21 | |||
| Variance | 67.34 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | 1.43 | |||
| Maximum Drawdown | 66.67 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Amarantus Bioscience Backtested Returns
Amarantus Bioscience secures Sharpe Ratio (or Efficiency) of -0.18, which signifies that the company had a -0.18 % return per unit of standard deviation over the last 3 months. Amarantus Bioscience Holdings exposes thirteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amarantus Bioscience's risk adjusted performance of (0.08), and Mean Deviation of 1.99 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.71, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Amarantus Bioscience are expected to decrease at a much lower rate. During the bear market, Amarantus Bioscience is likely to outperform the market. At this point, Amarantus Bioscience has a negative expected return of -2.78%. Please make sure to confirm Amarantus Bioscience's risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to decide if Amarantus Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Amarantus Bioscience Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between Amarantus Bioscience time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amarantus Bioscience price movement. The serial correlation of 0.0 indicates that just 0.0% of current Amarantus Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Amarantus Bioscience Holdings reported net income of (10.58 Million). This is 103.1% lower than that of the Biotechnology sector and 115.11% lower than that of the Health Care industry. The net income for all United States stocks is 101.85% higher than that of the company.
Amarantus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amarantus Bioscience's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amarantus Bioscience could also be used in its relative valuation, which is a method of valuing Amarantus Bioscience by comparing valuation metrics of similar companies.Amarantus Bioscience is currently under evaluation in net income category among its peers.
Amarantus Fundamentals
| Current Valuation | 6.59 M | |||
| Shares Outstanding | 68.27 M | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 53.19 X | |||
| EBITDA | (20.79 M) | |||
| Net Income | (10.58 M) | |||
| Cash And Equivalents | 178 | |||
| Total Debt | 20.72 M | |||
| Debt To Equity | 0.84 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 9.0 | |||
| Number Of Employees | 19 | |||
| Beta | 1.67 | |||
| Market Capitalization | 3.13 M | |||
| Total Asset | 3.48 M | |||
| Retained Earnings | (104.87 M) | |||
| Working Capital | (14.89 M) | |||
| Current Asset | 942 K | |||
| Current Liabilities | 15.83 M | |||
| Z Score | -63.3 | |||
| Net Asset | 3.48 M |
About Amarantus Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amarantus Bioscience Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amarantus Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amarantus Bioscience Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.